کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3838439 | 1247720 | 2015 | 6 صفحه PDF | دانلود رایگان |
The skeleton has structural and locomotor functions, and is a mineral reservoir. Bone turnover by osteoclasts and osteoblasts is a lifelong process, incorporating growth, modelling and remodelling to repair microdamage and access the mineral reservoir.Signalling between bone cells is essential for the coordination of these processes. Osteoblasts regulate osteoclast activity through the receptor activator of nuclear factor-κB (RANK)/RANK ligand/osteoprotegerin system, and osteocytes regulate osteoblast activity through sclerostin secretion.If resorption and formation are balanced there is no net change in bone mass after each cycle, but with ageing and some disease states resorption exceeds formation leading to remodelling imbalance, decreased bone mass and loss of microstructural integrity.The rate of remodelling is determined by loading and endocrine influences. The most important endocrine regulator of bone turnover is probably oestrogen, but other hormones regulating bone metabolism include insulin-like growth factor-1, parathyroid hormone and gut and adipocyte hormones.
Journal: Surgery (Oxford) - Volume 33, Issue 1, January 2015, Pages 1–6